Skip to content

Caffeine for protection from kidney failure in babies who do not breathe or cry at birth

Caffeine for the Prevention of Acute Kidney Injury in Neonates with Perinatal Asphyxia: A Randomized Controlled Trial - Nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073008
Enrollment
74
Registered
2024-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P019- Newborn affected by maternal complication of pregnancy, unspecified

Interventions

Intervention1: Inj caffeine citrate: After initial resuscitation and delivery room stabilization, neonate will receive a single intravenous injection of caffeine citrate at a dose of 20 mg per kg at a

Sponsors

All India Institute of Medical Sciences, Rishikesh
Lead Sponsor
Sriparna Basu
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Neonates with gestational age more than equal to 35 weeks with perinatal asphyxia. Perinatal asphyxia will be defined as per the National Institutes of Child Health and Human Development criteria.

Exclusion criteria

Exclusion criteria: 1. Major congenital malformation including antenatal detected congenital anomalies of the kidneys and urinary tracts 2. Born to mothers with renal failure and beyond as per RIFLE criteria of acute kidney injury

Design outcomes

Primary

MeasureTime frame
The proportion of neonates developing acute kidney injury. Acute kidney injury will be defined as per Kidney Disease Improving Global Outcomes criteria.Timepoint: Within first 7 days of life.

Secondary

MeasureTime frame
Severity of acute kidney injury, if developed 2. Levels of serum cystatin C at 24, plus minus 6 hours of life 3. Incidence and severity of hypoxic-ischemic encephalopathy 4. Incidence of seizures 5. Serial monitoring of A. aEEG background pattern B. Cranial USG and anterior cerebral artery blood flow C. Cerebral and renal regional tissue oxygenation using near-infrared spectroscopy 6. Need and duration of respiratory support 7. Adverse effects of caffeine administration 8. Morbidities during the hospital stay 9. Mortality 10. Change in weight Z score from birth to discharge 11. Hammersmith Neonatal Neurological Examination at discharge 12.Developmental screening at follow up Timepoint: During hospital stay and during follow up

Countries

India

Contacts

Public ContactSriparna Basu

All India Institute of Medical Sciences, Rishikesh

pavanakumarsk49@gmail.com9916890369

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026